Page last updated: 2024-09-02

deoxyglucose and Endometrial Neoplasms

deoxyglucose has been researched along with Endometrial Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kusuhara, M; Urakami, K; Yamaguchi, K; Zangiacomi, V1
Daudi, S; Griffith, K; Kshirsagar, M; Liu, JR; Rhode, J; Tan, L; Wahl, H1
Chitcholtan, K; Evans, JJ; Sykes, PH1
Emons, G; Gründker, C; Reutter, M1
Carvajal, A; de los Angeles Garcia, M; Espinoza, N; Gúzman, C; Kato, S; Medina, RA; Meneses, AM; Monsó, C; Nualart, F; Owen, GI; Pinto, M; Rodriguez, F; Vera, JC1

Other Studies

5 other study(ies) available for deoxyglucose and Endometrial Neoplasms

ArticleYear
Impact of 2-deoxy-D-glucose on the target metabolome profile of a human endometrial cancer cell line.
    Biomedical research (Tokyo, Japan), 2013, Volume: 34, Issue:5

    Topics: Cell Line, Tumor; Deoxyglucose; Endometrial Neoplasms; Female; Glucose-6-Phosphate Isomerase; Humans; Metabolic Networks and Pathways; Metabolome; Metabolomics

2013
Expression of metabolically targeted biomarkers in endometrial carcinoma.
    Gynecologic oncology, 2010, Volume: 116, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Deoxyglucose; Drug Delivery Systems; Drug Synergism; Endometrial Neoplasms; Female; Glucose Transporter Type 1; Humans; Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2010
The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.
    Journal of translational medicine, 2012, Mar-06, Volume: 10

    Topics: 4-Chloro-7-nitrobenzofurazan; Antioxidants; Apoptosis; Cell Proliferation; Cell Survival; Cisplatin; Densitometry; Deoxyglucose; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Extracellular Signal-Regulated MAP Kinases; Female; Glucose; Glucose Transporter Type 1; Humans; Integrin beta1; Intracellular Space; Phosphorylation; Proto-Oncogene Proteins c-akt; Spheroids, Cellular; Superoxide Dismutase; Tissue Culture Techniques; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2012
Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cell Line, Tumor; Cell Survival; Deoxyglucose; Drug Evaluation, Preclinical; Drug Synergism; Endometrial Neoplasms; Female; Glycolysis; Humans; Molecular Targeted Therapy; Ovarian Neoplasms; Receptors, LHRH; Starvation; Treatment Outcome

2013
Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells.
    The Journal of endocrinology, 2004, Volume: 182, Issue:3

    Topics: Biological Transport; Blotting, Western; Cell Line, Tumor; Deoxyglucose; Endometrial Neoplasms; Estrogens; Female; Gene Expression Regulation; Glucose Transporter Type 1; Glucose Transporter Type 2; Glucose Transporter Type 3; Glucose Transporter Type 4; Humans; Immunohistochemistry; Monosaccharide Transport Proteins; Muscle Proteins; Nerve Tissue Proteins; Progesterone; Reverse Transcriptase Polymerase Chain Reaction

2004